Multilingual Technologies Inc. attended the BayBio Conference about Investing Across Boarders

June 23, 2014

20140619_180736

On June 19, 2014, our account manager along with nearly 80 entrepreneurs, attorneys, attended the BayBio Conference sponsored by Onyx Pharmaceuticals and Chinese Bioscience Association.

The panel speakers, Dr. Graeme Martin (Takada Ventures), Dr. Wenbao Li (Morningside Group), Dr. Sofie Qiao (Wuxi Venture) and Dr. Min Cui (Decheng Capital) presented their focusing fields, stages, fund budges of their companies and shared their views about the current venture market of biotech/pharmaceutical industries. They disagreed with the sayings that the market right now was like bubbles about to burst, instead, they found it a good time for biotech/pharmaceutical investments. They mentioned that a good venture capital was much more than money. Investors will provide networking resources, business development consultant, and sometimes even free legal services to the entrepreneurs in order to help them get on the right track as soon as possible. In many cases, the cooperation between investors and entrepreneurs is more like a marriage than business partnership. So the entrepreneurs would need to choose the investors they like at the beginning.

The investment of the Asian market or US-Asian hybrid market are proved to be a challenge to many investors. Language barrier, culture difference, lack of local connection will all prevent the IPO from smoothly processed. It is important to partner with local marketing companies, localization companies, and local ventures to ensure successful listing.

Our company, Multilingual Technologies Inc. have done extensive Life Sciences material translation and localization work for dozens of international biotech and pharmaceutical companies. With biotech and pharmaceutical experts on staff, we have particular insight and expertise providing technical translations to Life Sciences corporations. We would be very happy to partner with biotech/pharmaceutical entrepreneurs with their IPO processing and business expansion to the other nations. For more details, please contact us at info@multilingual-tech.com.